Latest Hyperfibrinolysis Stories

2009-01-20 13:40:29

The U.S. Food and Drug Administration has approved RiaSTAP for the treatment of bleeding in patients with a rare genetic defect. People with the defect -- congenital fibrinogen deficiency -- are unable to make sufficient amounts of fibrinogen, which plays an important role in blood coagulation by helping to form blood clots and prevent bleeding. This product offers much-needed treatment for the small number of patients with congenital fibrinogen deficiency, said Dr. Jesse Goodman, director of...

Word of the Day
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.